Obesity is increasingly referred to as a chronic disease. This is also how it is defined in the recommendations of scientific ...

As obesity medicine continues to evolve, integrating sleep health into obesity treatment plans is essential.Poor sleep ...

The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use ...

By Michele Gershberg and Michael Erman PHILADELPHIA, March 16 (Reuters) - The CEO of Roche's Genentech unit, Ashley Magargee, ...

Theres no question that medications like semaglutide (Wegovy) and tirzepatide (Zepbound) make headlines. Theyre two of the handful of medications approved specifically for weight loss. While both can ...

According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...

Acetazolamide plus atomoxetine improved nocturnal CO2 and oxygenation in OHS. Find out more about this proof-of-concept trial ...

A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent ...

AbbVie Inc. (NYSE:ABBV) is one of Goldman Sachs top healthcare stocks. On March 9, William Blair reiterated an Outperform ...

Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat ...

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a clinical-stage biotechnology company developing a pipeline of ...

Medical societies on Tuesday warned that delayed treatment of obesity is contributing to the increasing number of Filipinos developing heart, kidney and metabolic diseases. At a press briefing, the ...